Literature DB >> 23292125

Epitope-specific immune recognition of the nontypeable Haemophilus influenzae outer membrane protein 26.

Duangkamol Kunthalert1, Laura A Novotny, Helen M Massa, Glen C Ulett, Lauren O Bakaletz, Jennelle M Kyd, Allan W Cripps.   

Abstract

Previous studies using rodent respiratory infection models of nontypeable Haemophilus influenzae (NTHi) infection have established the 26-kDa outer membrane protein of the bacterium, OMP26, as a potential vaccine antigen for NTHi. This study undertook a comprehensive immunological identification of OMP26 T- and B-cell epitopes. A series of OMP26 peptides were constructed and regions of the OMP26 antigen involved in recognition by lymphocyte receptors and induction of acquired immune responses were identified. The dominant T-cell epitopes for OMP26 were located toward the C-terminus between amino acid residues 95 and 197 (T3+T4 region) as mapped using antigen-specific lymphocyte proliferation assays. The newly identified T-cell epitopes exhibited strong capacity for efficient T-cell activation, suggesting that, compared with other OMP26 regions; epitopes within the T3+T4 region have the highest affinity for binding to major histocompatibility complex molecules. In contrast, the predominant B-cell epitopes of OMP26 were located more centrally within the molecule between amino acid residues 45 and 145 (T2+T3 region) as determined using enzyme-linked immunosorbent assay and surface plasmon resonance assays. The T2+T3 region was immunodominant in several species including chinchilla, mice and rats when assessed using both mucosal and parenteral immunization regimes. In addition, the antibodies directed against the T2+T3 region bound to intact NTHi cell surface, according to flow cytometry. Collectively, these results specifically locate the amino acid sequences containing the OMP26 T- and B-cell epitopes, which, as newly mapped antigenic epitopes for lymphocyte recognition, will be useful to improve existing NTHi vaccine strategies. Comprehensive definition of the minimum epitope length required for optimal B- and T-cell responses requires further study.

Entities:  

Keywords:  B and T-cell epitopes; OMP26; immune response; mucosal; nontypeable Haemophilus influenzae; outer membrane protein; parenteral; peptide vaccine; vaccine

Mesh:

Substances:

Year:  2013        PMID: 23292125      PMCID: PMC3891721          DOI: 10.4161/hv.23255

Source DB:  PubMed          Journal:  Hum Vaccin Immunother        ISSN: 2164-5515            Impact factor:   3.452


  39 in total

1.  Peptide and recombinant antigens for protection against bacterial middle ear infection.

Authors:  L O Bakaletz
Journal:  Vaccine       Date:  2001-03-21       Impact factor: 3.641

Review 2.  Antigenicity and immunogenicity of synthetic peptides.

Authors:  M H Van Regenmortel
Journal:  Biologicals       Date:  2001 Sep-Dec       Impact factor: 1.856

3.  Epitope mapping by surface plasmon resonance in the BIAcore.

Authors:  B Johne
Journal:  Mol Biotechnol       Date:  1998-02       Impact factor: 2.695

4.  Synthesis, characterization, and immunologic properties of detoxified lipooligosaccharide from nontypeable Haemophilus influenzae conjugated to proteins.

Authors:  X X Gu; C M Tsai; T Ueyama; S J Barenkamp; J B Robbins; D J Lim
Journal:  Infect Immun       Date:  1996-10       Impact factor: 3.441

5.  Deconstructing the antigenic profile of a protective epitope from measles virus fusion protein using overlapping peptides.

Authors:  C D Partidos; F B Salani; J Ripley; M W Steward
Journal:  Vaccine       Date:  1999-09       Impact factor: 3.641

6.  Potential of a novel protein, OMP26, from nontypeable Haemophilus influenzae to enhance pulmonary clearance in a rat model.

Authors:  J M Kyd; A W Cripps
Journal:  Infect Immun       Date:  1998-05       Impact factor: 3.441

Review 7.  Peptide competition for antigen presentation.

Authors:  L Adorini; Z A Nagy
Journal:  Immunol Today       Date:  1990-01

8.  Epitope mapping of the outer membrane protein P5-homologous fimbrin adhesin of nontypeable Haemophilus influenzae.

Authors:  L A Novotny; J A Jurcisek; M E Pichichero; L O Bakaletz
Journal:  Infect Immun       Date:  2000-04       Impact factor: 3.441

9.  Redistribution of a murine humoral immune response following removal of an immunodominant B cell epitope from a recombinant fusion protein.

Authors:  J P Scheerlinck; R DeLeys; E Saman; L Brys; A Geldhof; P De Baetselier
Journal:  Mol Immunol       Date:  1993-06       Impact factor: 4.407

10.  Enhancement of pulmonary clearance of Moraxella (Branhamella) catarrhalis following immunization with outer membrane protein CD in a mouse model.

Authors:  T F Murphy; J M Kyd; A John; C Kirkham; A W Cripps
Journal:  J Infect Dis       Date:  1998-12       Impact factor: 5.226

View more
  1 in total

Review 1.  Panel 6: Vaccines.

Authors:  Melinda M Pettigrew; Mark R Alderson; Lauren O Bakaletz; Stephen J Barenkamp; Anders P Hakansson; Kevin M Mason; Johanna Nokso-Koivisto; Janak Patel; Stephen I Pelton; Timothy F Murphy
Journal:  Otolaryngol Head Neck Surg       Date:  2017-04       Impact factor: 3.497

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.